by | Nov 14, 2019 | Nichols, Colin, Remedi, Maria
— This is a CRISPR/Cas9 germline mutation in the KCNJ8 gene, equivalent to a human Cantu Syndrome mutation. The mouse is therefore a genetic model of human Cantu Syndrome. This mouse model can be used for pre-clinical testing of targeted therapy for Cantu Syndrome.
Publication: Cardiovascular consequ…
by | Oct 22, 2019 | Miner, Jeffrey
by | Oct 22, 2019 | Barratt, Michael, Chang, Hao-Wei, Gehrig, Jeanette, Gordon, Jeffrey, Venkatesh, Siddarth
— Technology Description
Prof. Jeffrey Gordon and his colleagues have developed an inexpensive food formulation that could treat malnutrition and a range of associated health problems by repairing the gut microbiome. Children who are malnourished are currently treated with supplemental nutrition tha…
by | Oct 22, 2019 | Blumer, Kendall, Onken, Michael
— Disease indication – Uveal melanoma and other G protein-driven disorders, including other cancers (certain vascular tumors, colon, lung, adenocarcinoma, skin melanoma, thyroid adenoma), cholera and Sturge-Weber Syndrome
Drug format – small molecule (FR900359, a bioavailable inhibitor of…
by | Oct 22, 2019 | Mennerick, Steven, Sun, Min-Yu, Taylor, Amanda, Zorumski, Charles
— Disease indication – neuroprotection in stroke/ischemia with potential for treating other neurodegenerative diseases
Drug format – neurosteroid
Drug class – drug repurposing (25-hydroxycholesterol)
Research stage and Preliminary data:
In vitro – The inventors demonstrated…